City

Beijing (1)

Xi'an (1)

Condition

Type 2 Diabetes Mellitus With Complication (3)

Overall Status

Not yet recruiting (2)

Recruiting (1)

Sign in for free

Phase

n/a (1)

phase 4 (1)

Sponsor

First Affiliated Hospital Xi'an Jiaotong University (2)

Peking Union Medical College Hospital (1)

Collaborator

Affiliated Hospital of Chengde Medical University (1)

Chinese Academy of Sciences (1)

First Affiliated Hospital of Harbin Medical University (1)

Hangzhou Grand Biologic Pharmaceutical, Inc. (1)

The Affiliated Hospital of Inner Mongolia Medical University (1)

The First Affiliated Hospital of Zhengzhou University (1)

Intervention

canagliflozin (2)

pioglitazone (2)

bifidobacterium, lactobacillus, enterococcus and bacillus cereus tablets, live (1)

siliankang simulating tablets (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational [Patient Registry] (1)

type 2 diabetes mellitus with complication

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Type 2 Diabetes With Complication Trial in Xi'an (Canagliflozin, Pioglitazone)

Recruiting

Type 2 Diabetes Mellitus With Complication

Xi'an, Shannxi, China

First Affiliated Hospital Xi'an Jiaotong University

Aug 22, 2022

Type 2 Diabetes With Complication Trial (Canagliflozin, Pioglitazone)

Not yet recruiting

Type 2 Diabetes Mellitus With Complication

(no location specified)

Jul 5, 2022

Type 2 Diabetes With Complication Trial in Beijing (Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets,

Not yet recruiting

Type 2 Diabetes Mellitus With Complication

Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live
Siliankang simulating tablets

Beijing, Beijing, China

Peking Union Medical College Hospital

Jul 23, 2021